Ads by Google
Product Introduction
To produce micro-encapsulated fish, fish is emulsified in an aqueous solution of coating agent and antioxidants, sprayed and then dried. At all stages, the oxidation-sensitive raw material is treated under controlled conditions. The result is an oxidation-stable free-flowing powder.
Product Details
Description and solubility | Light-yellow to light-beige, free-flowing, dry powder. The microencapsulated fish oil rich in EPA and DHA. Dispersible in cold water (approx. 10 – 15 °C), to form a milky emulsion with good long-term stability. |
Specifications | EPA: min. 4.1 weight-%* DHA: min. 2.7 weight-%* * calculated as triglycerides |
Features | The product shows excellent dispersibility in cold water. |
Composition | Fish oil, sucrose, corn starch, caseinate, sodium ascorbate, tricalcium phosphate, tocopherol, lecithin, ascorbyl palmitate. |
Application | The product is suitable for the fortification of most food products. |
Storage/Handling
The product is sensitive to air, heat, and light. Stored in the tightly sealed, lightproof packaging in a cool place. Once opened, it is recommended to use the remaining contents as quickly as possible.
Physiological importance
The essential n-3 fatty acid α-linolenic acid (C18:3) serves as an energy carrier and precursor for the synthesis of EPA (C20:5) and DHA (C22:6) into which it is converted by chain elongation and introduction of extra double bonds. EPA is an important component of the phospholipids of cell membranes and lipoproteins. It also serves as a precursor in the synthesis of eicosanoids, which have a regulatory function on tissue hormones. DHA is a structural component in the cell membranes, particularly the nervous tissue of the brain, and plays an important role both for the synapses and the cells of the retina.
The conversion of α-linolenic acid to its long-chain derivatives EPA and DHA may not be sufficient to maintain optimal body functions. The limited conversion is mainly due to a dramatic change in eating habits during the past 150 years, resulting in increased n-6 PUFA intake and concomitant decrease in n-3 LCPUFA consumption in most industrialized countries. Therefore, the n-6 to n-3 ratio in our diet has changed from 2:1 to about 10 – 20:1. This change accounts for the inadequate biosynthesis of the biologically active n-3 PUFA, EPA, and DHA, as n-6 and n-3 PUFA compete for the same desaturase and elongase enzyme systems.
EPA-derived eicosanoids affect immunological processes and fulfill anti-inflammatory functions. In addition, n-3 fatty acids have “noneicosanoid” functions attributed to their physical properties. They are able to modify the membrane fluidity, which is of particular relevance in terms of erythrocytes.
Photo Show
What is NNET?
A nano-emulsion preparation technique with the aid of analytical techniques and computer design, selects the method of self-emulsifying or physical homogeneous to produce water-soluble preparation of insoluble compounds as well as protect and increase its bioactivity in oral route.
As a technology used in health care and food industry, NNET platform has the following significant advantages:
*Simple excipients and concise process.
*Effectively maintain the biological activity of the raw materials.
*Effectively improve the oral absorption while improve the water-solubility.
*Complete with safety excipients.
Factory Show
Leading by CAS academician, a scholastic committee is found by experts, professors and industry professionals to guide our R&D.
Over ten PhD and Master form up the development team to investigate into the new formulation application for fulfilling the demands of market
A multi-million research center in the facility is proven to provide a comprehensive research and assay service for all customers.
Our Trade Show
CPhI Shanghai China booth No.W1Q12 June 26-28, 2012
EPA Powder